Evidence map›Paper›PMID 40978380›Full record

ArticleACS omega2025

Design, Synthesis, and Trypanosomicidal Evaluation of Eugenol-Based Azole Hybrids: Discovery of an

José Vaz Cardoso Machado, Clara Oliveira de Carvalho Lopes, Sarah Ferreira Maciel, Valquíria Ângelis Fernandes, Sara Manuela Mendonça da Silva Cravo, Maria Emília da Silva Pereira de Sousa, Maria Elizabeth Tiritan, Thiago Belarmino de Souza, Lucas Lopardi Franco, Lívia de Figueiredo Diniz and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS omega, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

José Vaz Cardoso MachadoFaculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, MG 37130-001, Brazil.
Clara Oliveira de Carvalho LopesFaculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, MG 37130-001, Brazil.
Sarah Ferreira MacielFaculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, MG 37130-001, Brazil.
Valquíria Ângelis FernandesFaculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, MG 37130-001, Brazil.
Sara Manuela Mendonça da Silva CravoFaculdade de Farmácia, Universidade do Porto, Porto 4099-002, Portugal.
Maria Emília da Silva Pereira de SousaFaculdade de Farmácia, Universidade do Porto, Porto 4099-002, Portugal.ORCID https://orcid.org/0000-0002-5397-4672
Maria Elizabeth TiritanFaculdade de Farmácia, Universidade do Porto, Porto 4099-002, Portugal.
Thiago Belarmino de SouzaEscola de Farmácia, Universidade Federal de Ouro Preto, Ouro Preto, MG 35400-000, Brazil.
Lucas Lopardi FrancoFaculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, MG 37130-001, Brazil.
Lívia de Figueiredo DinizInstituto de Ciências Biomédicas, Universidade Federal de Alfenas, Alfenas, MG 37130-001, Brazil.ORCID https://orcid.org/0000-0001-9398-6478
Diogo Teixeira CarvalhoFaculdade de Ciências Farmacêuticas, Universidade Federal de Alfenas, Alfenas, MG 37130-001, Brazil.ORCID https://orcid.org/0000-0002-6362-2822

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chagas disease, caused by

Identifiers

PMID40978380
PMCPMC12444550

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.